Abstract:OBJECTIVE:To observe the serial changes of plasma microparticle procoagulant activity in patients with traumatic brain injury (TBI) and evaluate its correlations with outcome and pathophysiology of TBI.METHODS:A total of 139 consecutive patients with isolated moderate or severe head trauma and 40 age- and sex-matched healthy controls were enrolled. Plasma samples were obtained on entry in healthy controls, as well as on admission and at day 1, day 2, day 3, day 5, and day 7 after TBI in the patients. Its concentration was measured by a prothrombinase assay.RESULTS:Fifty patients (36.0%) died from TBI in a month. After TBI, plasma microparticle procoagulant activity in the patients increased during the 6-hour period immediately, peaked in 24 hours and decreased gradually thereafter. It was substantially higher than that of healthy controls during the 7-day period using analysis of covariate (P < 0.01). A multivariate analysis selected plasma microparticle procoagulant activity (OR 1.432, 95% CI 1.194-1.719, P < 0. 01) as an independent predictor for 1-month mortality. Plasma microparticle procoagulant activities of non-survivals were statistically significantly higher than those of survivals (P = 0.01), and plasma microparticle procoagulant activities of patients with severe TBI were obviously higher than those of patients with moderate TBI (P = 0.002) using repeated-measures analysis. Plasma microparticle procoagulant activities of patients were negatively associated with Glasgow coma scale scores using Spearman correlation coefficient (P < 0.05). A multivariate linear regression selected plasma D-dimer level (P = 0.012) and plasma C-creative protein level (P = 0.019) related to plasma microparticle procoagulant activities. A receiver operating characteristic curve identified the cutoff levels of plasma microparticle procoagulant activities (12.2 U/ml) predicting 1-month mortality of patients with the high sensitivity (72.0%) and specificity values (85.4%). Areas under curve (AUC) of plasma resistin level (AUC = 0.847 +/- 0.037) was smaller than those of GCS scores (AUC = 0.917 +/- 0.023), but this difference failed to reach statistical significance (P = 0.104).CONCLUSION:Increased activity of plasma microparticle procoagulant is found after traumatic brain injury. It may contribute to inflammatory reaction and coagulation cascade and is associated with a poor clinical outcome.

Clinical Evaluation of Prognosis of Severe Posttraumatic Brain Injuries by Using S-100B

High S100B Levels in Cerebrospinal Fluid and Peripheral Blood of Patients with Acute Basal Ganglial Hemorrhage Are Associated with Poor Outcome.

Role of S-100B,NSE and MBP in Prediction of Prognosis in Patients with Severe Head Injury

The predictive value of S-100B and NSE in outcome of patients with severe head injury

Relationship between cerebrospinal fluidα-Synuclein and prognosis of patients with traumatic brain injury

Serum S-100B for mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy

Change in Plasma Microparticle Procoagulant Activity after Traumatic Brain Injury

S-100B and Neuron Specific Enolase in Outcome Prediction of Severe Head Injury

Application significance of S100B in the assessment of blood-brain barrier injury

Serum S-100B protein as a molecular marker in severe traumatic brain injury

S100 Protein and Brain Injury Induced by Extracorporeal Circulation

Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury

Evaluation of severe brain injury prognosis by neuron-specific enolase, myelin basic protein

Effect of Non-Cerebral Trauma on the Value of Serum S100B

[Relationship Between Serum S100B Protein Level and Brain Damage in Preterm Infants].

Colloidal gold-based immunochromatographic biosensor for quantitative detection of S100B in serum samples

Role of Diffusion Tensor Imaging Combined with Neuron-Specific Enolase and S100 Calcium-binding Protein B Detection in Predicting the Prognosis of Moderate and Severe Traumatic Brain Injury

Correlation between the expression of β2-microglobulin and S100 calcium binding protein B in cerebrospinal fluid and the occurrence of communicating hydrocephalus after traumatic brain injury

S100B Protein and Neonatal Brain Injury:a Meta-analysis

The quantitative analysis of S100 in the brain tissue and serum following diffusebrain injury in rats

Diagnostic and Prognostic Values of S100B versus Neuron Specific Enolase for Traumatic Brain Injury; a Systematic Review and Meta-analysis